ACKB Ackermans & van Haaren NV

Ackermans & van Haaren reports outstanding Q1-results at both DEME and at the private banks Delen and Van Breda, and gives confirmation of guidance: net profit of 2024 expected to be higher than last year

Ackermans & van Haaren reports outstanding Q1-results at both DEME and at the private banks Delen and Van Breda, and gives confirmation of guidance: net profit of 2024 expected to be higher than last year

Dear shareholder,

Dear Madam, Dear Sir,



Ackermans & van Haaren has published today its Trading Update on the 1st quarter of 2024, with the following key items:

  • Outstanding Q1-results at both DEME and at the private banks Delen and Van Breda
  • Confirmation of guidance: net profit of 2024 expected to be higher than last year

Please find in annex the full press release



Best regards

Ackermans & van Haaren

Attachment



EN
23/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ackermans & van Haaren NV

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ackermans & van Haaren: Results capping already strong subsidiary reporting. DPS beat. Fagron: Acquisition of Pharmavit Europe, active in nutraceutical raw materials. Fugro: Patience please. Kendrion: Sees signs of improvement in EU economy. Proximus: 2026 dividend halved, 2028-30 targets a bit better on lower capex. Proximus: 4Q25 in line EBITDA on weaker sales, FCF up; 2026 guidance below on EBITDA. Recticel: Strong FY25 results, CEO transition seen as a negative

Guy Sips ... (+7)
  • Guy Sips
  • Hilde Van Boxstael
  • Livio Luyten
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Wim Hoste
  • Wim Lewi

Morning Notes : ACKB BB, FAGR BB, FUR NA, MTLS US, MDXH BB, PROX BB, R...

: ACKB BB, FAGR BB, FUR NA, MTLS US, MDXH BB, PROX BB, RECT BB, WHATS BB

ResearchPool Subscriptions

Get the most out of your insights

Get in touch